{"nct_id":"NCT02968563","title":"Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2021-12","start_date":"2016-12-13","start_date_type":"ACTUAL","primary_completion_date":"2019-06-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}